Nouscom Nouscom is a biotech company working to develop a series of new, potent immunotherapeutics capable of selectively killing tumor cells.
| Repair Biotechnologies Repair Biotechnologies is developing therapies with the goals of reversing atherosclerosis and atrophy of the thymus. | ||
Founding Date | Founding Date 2015 | Founding Date 2018 | Founding Date 2019 |
Type | Type Private | Type Private | Type Private |
Tags | |||
Locations | Locations Basel, CH HQ Roma, IT | Locations Syracuse, US HQ | Locations Waltham, US HQ |
Employees | Employees 50 | Employees 8 | Employees 695% decrease |
Funding | |||
Latest funding round | Latest funding round $ 49m (almost 7 years ago) | Latest funding round $ 2.2m (over 5 years ago) | Latest funding round $ 60m (over 4 years ago) |
Total funding raised | Total funding raised $ 62.6m | Total funding raised $ 2.2m | Total funding raised $ 60m |